Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|April 14, 2021
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitorsGiovanni Fucà, Francesca Corti, Margherita Ambrosini, et al.Clinical Colorectal Cancer|June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of MilanFilippo Pietrantonio, Federica Morano, Monica Niger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance TherapyFederica Morano, Salvatore Corallo, Sara Lonardi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal CancerPaolo Manca, Salvatore Corallo, Adele Busico, et al.Clinical Colorectal Cancer|December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE StudyCarlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2023
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO FoundationSara Lonardi, Cosimo Rasola, Riccardo Lobefaro, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2024
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trialsAlessandra Raimondi, Young Woo Kim, Won Ki Kang, et al.JCO Precision Oncology|February 1, 2022
Atypical <i>RAS</i> Mutations in Metastatic Colorectal CancerFilippo Pietrantonio, Rona Yaeger, Alexa B Schrock, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2021
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino studyAlessandra Raimondi, Salvatore Corallo, Sara Lonardi, et al.Pageof 8